Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O2EF
|
|||
Drug Name |
PMID25991433-Compound-Q2
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
UNIVERSIT DEGLI STUDI DI BARI [IT]
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H20N2O6
|
|||
Canonical SMILES |
COC1=CC(=CC(=C1OC)OC)NC(=O)C2=C(C=C(C=C2)C3=CC=CC=C3)[N+](=O)[O-]
|
|||
InChI |
1S/C22H20N2O6/c1-28-19-12-16(13-20(29-2)21(19)30-3)23-22(25)17-10-9-15(11-18(17)24(26)27)14-7-5-4-6-8-14/h4-13H,1-3H3,(H,23,25)
|
|||
InChIKey |
RCEYITFFDFXLHB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Mitogen-activated protein kinase (MAPK) | Target Info | Inhibitor | [1] |
Target's Patent Info | Mitogen-activated protein kinase (MAPK) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.